AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章，直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0 经验分享：投稿后5天分配审稿人，2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供，应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。David201514 2019-11-21 00:00:00 发表: 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]

2022-04-19 ms1000002016377873

这个刊meta和网络药理学可以吗

35 0

[GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章，直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0 经验分享：投稿后5天分配审稿人，2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供，应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。David201514 2019-11-21 00:00:00 发表: 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]

2021-12-29 MS68862005

俢回的流程是什么？

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章，直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0 经验分享：投稿后5天分配审稿人，2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供，应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。David201514 2019-11-21 00:00:00 发表: 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

审稿的流程是什么？

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章，直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0 经验分享：投稿后5天分配审稿人，2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供，应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。David201514 2019-11-21 00:00:00 发表: 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]

2020-11-21 124022a9m79暂无昵称

临床的文章，直接秒拒

1 0

[GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章，直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0 经验分享：投稿后5天分配审稿人，2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供，应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。David201514 2019-11-21 00:00:00 发表: 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]

2019-11-21 David201514

审稿速度:1.0 | 投稿命中率:25.0
经验分享：2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。

209 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章，直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0 经验分享：投稿后5天分配审稿人，2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供，应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。David201514 2019-11-21 00:00:00 发表: 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]

2020-02-10 123cda6em39(暂无昵称)

审稿速度:1.0
经验分享：投稿后5天分配审稿人，2周拒稿

131 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章，直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0 经验分享：投稿后5天分配审稿人，2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供，应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。David201514 2019-11-21 00:00:00 发表: 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]

2020-05-08 David201514

我的没有要求提供，应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表:
想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～

183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～

97 0

[GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章，直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0 经验分享：投稿后5天分配审稿人，2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供，应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。David201514 2019-11-21 00:00:00 发表: 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]

2020-02-18 123a6632m26暂无昵称

想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～David201514 2019-11-21 发表::
接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。David201514 2019-11-21 00:00:00 发表:
2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。

David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。

110 0

[GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章，直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0 经验分享：投稿后5天分配审稿人，2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供，应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。David201514 2019-11-21 00:00:00 发表: 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

求经验分享

203 0

[GetPortalCommentsPageByObjectIdResponse(id=1212400, encodeId=c01612124009f, content=这个刊meta和网络药理学可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dcd25717442, createdName=ms1000002016377873, createdTime=Tue Apr 19 08:35:29 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086507, encodeId=9a6f108650eaf, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086508, encodeId=6f9410865089a, content=审稿的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900925, encodeId=223790092512, content=临床的文章，直接秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab542455078, createdName=124022a9m79暂无昵称, createdTime=Sat Nov 21 02:27:36 CST 2020, time=2020-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580231, encodeId=510e580231b4, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584502, encodeId=f09658450205, content=审稿速度:1.0 经验分享：投稿后5天分配审稿人，2周拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=131, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84bd2438626, createdName=123cda6em39(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590476, encodeId=65125904e638, content=我的没有要求提供，应该是看审稿人意见吧183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, beContent=183****1026暂无昵称 2020-02-18 00:00:00 发表: 想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/10/873424c7509107856f96be26c270e89f.jpg, createdBy=0c9b1935072, createdName=David201514, createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584898, encodeId=2853584898bf, content=想请问一下，原始数据是接收前提供还是接收后提供呀，谢谢～David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。David201514 2019-11-21 00:00:00 发表: 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, beContent=David201514 2019-11-21 发表:: 接收率：约25% 审稿时间：约1个月 2019.02.13提交，3月中旬一审回，中间耽搁了一下，四月中修回，五月初接收。审稿挺快的，三个审稿人，还比较专业认真。内容丰富一点的还是蛮好投中的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43d42425724, createdName=123a6632m26暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578593, encodeId=2ada5e859317, content=求经验分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557790, encodeId=e33255e79013, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7dc1749684, createdName=mingwunl, createdTime=Sat Jun 09 16:23:00 CST 2018, time=2018-06-09, status=1, ipAttribution=)]

2018-06-09 mingwunl

审稿速度:1.0 | 投稿命中率:25.0
经验分享：老牌杂志.质量高.审稿人很专业.能提出比较好的建议.以便进一步提高文章质量.审稿速度也比较快.

254 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务